Leadership Overview
Divi's Laboratories has 4 executives leading key functions including strategy, operations, finance, and information technology.
Driven by a commitment to excellence, Divi's Laboratories specializes in the custom synthesis of generic APIs, intermediates, and nutraceutical ingredients, impacting global health through reliable pharmaceutical manufacturing.
Driven by a commitment to excellence, Divi's Laboratories specializes in the custom synthesis of generic APIs, intermediates, and nutraceutical ingredients, impacting global health through reliable pharmaceutical manufacturing.
Leadership Roles at Divi's Laboratories
Kiran Divi - Chief Executive Officer
Kiran Divi, the Chief Executive Officer at Divi's Laboratories, directs the overarching corporate strategy and market positioning for the company's specialized pharmaceutical manufacturing operations. Overseeing global expansion initiatives, the Chief Executive Officer ensures alignment with the company's mission to produce high-quality generic APIs, intermediates, and nutraceutical ingredients. This leadership role involves navigating complex regulatory landscapes and fostering innovation within the research and development divisions. By optimizing resource allocation and driving operational efficiencies, Kiran Divi directly impacts the company's ability to meet diverse international market demands. Ultimately, Divi's leadership secures sustained growth and reinforces Divi's Laboratories' standing as a key player in the Indian pharmaceutical sector.

Kishorebabu Lingamneni - Chief Financial Officer
Kishorebabu Lingamneni, the Chief Financial Officer at Divi's Laboratories, manages all financial operations, including budgeting, forecasting, and financial reporting for the company's extensive manufacturing activities. Overseeing capital allocation and investment strategies, the Chief Financial Officer ensures the financial health and sustainability of Divi's Laboratories' global operations. This position involves rigorous analysis of market trends and economic factors to inform strategic financial decisions. By optimizing financial structures and managing risk effectively, Kishorebabu Lingamneni directly supports the company's expansion into new markets and product lines. The financial acumen of Kishorebabu Lingamneni is essential for maintaining investor confidence and driving profitable growth in the dynamic pharmaceutical sector.
Manoranjan Jasti - Chief Information Officer
Manoranjan Jasti, the Chief Information Officer at Divi's Laboratories, leads the strategic development and implementation of information technology infrastructure across the organization's pharmaceutical manufacturing operations. Responsible for enhancing digital capabilities and ensuring data security, the Chief Information Officer drives innovation in IT systems to support business objectives. This role involves overseeing the integration of advanced technologies that streamline production processes and improve operational efficiency. By leveraging technology solutions, Manoranjan Jasti directly contributes to Divi's Laboratories' ability to maintain competitive advantages in a rapidly evolving industry. The technological vision of Manoranjan Jasti is crucial for optimizing data management and supporting the company's growth trajectory in the global pharmaceutical market.
Murali Divi - Managing Director
Murali Divi, the Managing Director at Divi's Laboratories, spearheads the operational execution and day-to-day management of the company's manufacturing facilities. Responsible for ensuring the seamless production of custom synthesizes generic APIs, intermediates, and nutraceutical ingredients, the Managing Director drives efficiency across all production lines. This critical role involves close collaboration with supply chain partners and quality control teams to maintain the highest standards of product integrity. By implementing advanced manufacturing techniques and optimizing production workflows, Murali Divi directly contributes to the company's capacity to fulfill large-scale global orders. The strategic oversight provided by Murali Divi is fundamental to Divi's Laboratories' reputation for reliability and timely delivery within the competitive pharmaceutical industry.
Explore Leadership Teams in Manufacturing
Founded in 2003, Phibro Animal Health Corporation is a global manufacturer and marketer of animal health pharmaceuticals, animal nutrition, and performance products. The company is headquartered in Teaneck, New Jersey.
Company Leadership
SL
RF
MG
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. It markets to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company is headquartered in Parsippany, New Jersey.
Company Leadership GT
RV
LP
MT
Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage each of its core therapeutic fields.
Company Leadership
MM
JS
MA
Parabolic Drugs Limited is a vertically integrated, research-based pharmaceutical manufacturer and exporter, specializing in the production of over 50 active pharmaceutical ingredients (APIs) and intermediates across various therapeutic segments. The company operates four large-scale facilities, including three state-of-the-art manufacturing plants and a custom synthesis and R&D center. With a focus on backward and forward integration, world-class infrastructure, and strong R&D capabilities, Parabolic Drugs is committed to delivering high-quality products. Their diverse product portfolio is supported by intellectual property rights, including Drug Master Files (DMFs) and patents for novel processes.
Company Leadership AN
AJ
VG
YB